Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaojun Zhang

Showing results (61-70 of 207) with videos related to

Pageof 21
Sort By:
Frontiers in Cardiovascular Medicine|November 17, 2022
Comparative analysis of instantaneous wave-free ratio and quantitative real-time myocardial contrast echocardiography for the assessment of myocardial perfusionLi Liang, Yongxiang Zhu, Fangfang Li, et al.
Chinese Medical Journal|November 29, 2023
Dietary intake and serum levels of copper and zinc and risk of hepatocellular carcinoma: A matched case-control studyXiaozhan Liu, Yaojun Zhang, Dinuerguli Yishake, et al.
International Journal of Surgery (London, England)|November 25, 2023
Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort studyZili Hu, Xiaohui Wang, Yizhen Fu, et al.
The Journal of Prosthetic Dentistry|June 20, 2026
Deviation analysis of guided fiber post removal using an assembled sleeveless guide system: A case seriesJingqi Zhu, Siyi Mo, Yuan Li, et al.
Frontiers in Immunology|December 4, 2024
Efficacy and safety of atezolizumab-bevacizumab vs pembrolizumab-lenvatinib in unresectable hepatocellular carcinoma: a retrospective, cohort studyZili Hu, Zhoutian Yang, Zibo Fu, et al.
Viruses|April 23, 2022
Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency AblationZili Hu, Huilan Zeng, Jingyu Hou, et al.
Journal of Hepatocellular Carcinoma|July 27, 2023
Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular CarcinomaZhenyun Yang, Zili Hu, Yizhen Fu, et al.
Communications Biology|January 7, 2023
Phase-separating pyrenoid proteins form complexes in the dilute phaseGuanhua He, Trevor GrandPre, Hugh Wilson, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|February 17, 2012
Elevated neutrophil to lymphocyte ratio might predict poor prognosis for colorectal liver metastasis after percutaneous radiofrequency ablationYaojun Zhang, Zhenwei Peng, Meixian Chen, et al.
Frontiers in Immunology|November 18, 2024
The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and PembrolizumabWeijie Wu, Zhenyun Yang, Hao Zou, et al.
Pageof 21

Showing results (61-70 of 207) with videos related to

Sort By:
Pageof 21
Frontiers in Cardiovascular Medicine|November 17, 2022
Comparative analysis of instantaneous wave-free ratio and quantitative real-time myocardial contrast echocardiography for the assessment of myocardial perfusionLi Liang, Yongxiang Zhu, Fangfang Li, et al.
Chinese Medical Journal|November 29, 2023
Dietary intake and serum levels of copper and zinc and risk of hepatocellular carcinoma: A matched case-control studyXiaozhan Liu, Yaojun Zhang, Dinuerguli Yishake, et al.
International Journal of Surgery (London, England)|November 25, 2023
Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort studyZili Hu, Xiaohui Wang, Yizhen Fu, et al.
The Journal of Prosthetic Dentistry|June 20, 2026
Deviation analysis of guided fiber post removal using an assembled sleeveless guide system: A case seriesJingqi Zhu, Siyi Mo, Yuan Li, et al.
Frontiers in Immunology|December 4, 2024
Efficacy and safety of atezolizumab-bevacizumab vs pembrolizumab-lenvatinib in unresectable hepatocellular carcinoma: a retrospective, cohort studyZili Hu, Zhoutian Yang, Zibo Fu, et al.
Viruses|April 23, 2022
Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency AblationZili Hu, Huilan Zeng, Jingyu Hou, et al.
Journal of Hepatocellular Carcinoma|July 27, 2023
Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular CarcinomaZhenyun Yang, Zili Hu, Yizhen Fu, et al.
Communications Biology|January 7, 2023
Phase-separating pyrenoid proteins form complexes in the dilute phaseGuanhua He, Trevor GrandPre, Hugh Wilson, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|February 17, 2012
Elevated neutrophil to lymphocyte ratio might predict poor prognosis for colorectal liver metastasis after percutaneous radiofrequency ablationYaojun Zhang, Zhenwei Peng, Meixian Chen, et al.
Frontiers in Immunology|November 18, 2024
The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and PembrolizumabWeijie Wu, Zhenyun Yang, Hao Zou, et al.
Pageof 21